Korro Bio (KRRO) Live Share Price, Invest From India

Korro Bio Stock Performance

as on August 22, 2026 at 2:16 pm IST

Day's Low
Day's High
$13.02
Day's Price Range
$13.48
$13.18
1.21%
Downside
2.28%
Upside
52 Week's Low
52 Week's High
$5.20
52-Week Price Range
$55.89
$13.18
60.51%
Downside
324.05%
Upside

Korro Bio share price movements today

Previous Close: $12.96
Open: $13.02
Volume: 219.5K
Market Cap: $195.6M
Day's Low - High: $13.02 - $13.48
52 Week Low - High: $5.20 - $55.89

Korro Bio Historical Returns

1 Month Return: + 8.41 %
3 Month Return: + 30.45 %
1 Year Return: -34.45 %
3 Year Return: 0 %
5 Year Return: 0 %

Korro Bio Stock Fundamentals & Key Indicators

Check Korro Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$195.6M

EPS (TTM)

-5.178

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-74.3M

Revenue (TTM)

2.4M

Profit Margin

0.00%

Return On Equity TTM

-97.69%

Korro Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Korro Bio with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Korro Bio	BUY	$195.6M	NA	NA	0.00%	NA
Revolution Medicines	BUY	$43.7B	669.3%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$128.2B	154.86%	29.82	86.04%	NA
Moderna	BUY	$25.3B	-84.24%	-7.98	-12.57%	NA
Regeneron	BUY	$82.7B	24.1%	19.24	84.86%	0.44999999999999996%

Stock Returns calculator for Korro Bio Stock including INR - Dollar returns

The Korro Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Korro Bio investment value today

Current value as on today

₹71,296

Returns

-₹28,704

(-28.7%)

Returns from Korro Bio Stock

-₹34,946 (-34.95%)

Dollar Impact

₹6,242 (+6.24%)

Analyst Recommendation on Korro Bio Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.88888888888889% of analysts recommend a 'BUY' rating for Korro Bio. Average target price of $20.2

Korro Bio Share Price Target

Get share price movements and forecasts by analysts on Korro Bio.

What analysts predicted

34.75%UPSIDE

Target Price

$20.2

Current Price

$13.18

Analyzed by

9 Analysts

Target

$20.20

Korro Bio target price $20.2, a slight upside of 34.75% compared to current price of $13.18. According to 9 analysts rating.

Indian Investors' Interest in Korro Bio Stock

Search interest for Korro Bio Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 24, 2026 to August 23, 2026

Change:-5% versus previous 30 day period

Korro Bio Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	2	2	1	1	1	-	-
Gross Profit	0	0	0	2	2	1	1	0	0	-
Operating Income	-21	-24	-23	-23	-25	-27	-19	-15	-20	-20
EBITDA	-20	-23	-22	-21	-23	-25	-16	-15	-20	-19
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	1	1	1	1	0	0	0
Income Before Tax	-19	-21	-21	-21	-23	-25	-18	-49	-19	-18
Income Tax Expense	0	0	0	0	-	0	-	0	0	0
Net Income	-19	-21	-20	-21	-23	-25	-18	-50	-19	-18
Net Profit Margin	0.00%	0.00%	0.00%	-933.47%	-917.14%	-1765.07%	-1656.97%	-3873.22%	0.00%	0.00%

Korro Bio Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	28	36	14	-	-	2	6
Gross Profit	12	35	10	-2	-3	2	2
Operating Income	-20	-27	-35	-58	-84	-91	-87
EBITDA	-17	-24	-33	-56	-80	-88	-83
Interest Expense	-	-	0	0	-	-	-
Depreciation	-	-	1	2	3	3	4
Income Before Tax	-18	-26	-21	-58	-81	-83	-116
Income Tax Expense	-	0	0	0	0	0	0
Net Income	-18	-26	-21	-58	-81	-83	-117
Net Profit Margin	-64.76%	-71.68%	-156.09%	0.00%	0.00%	-3680.36%	-1834.48%

Korro Bio Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-21	-20	-21	-23	-25	-18	-50	-19	-18
Operating Cash Flow	-14	-16	-7	-24	-19	-17	-17	-16	-16
Investing Cash Flow	-102	-12	-2	32	-11	7	14	-32	-17
Financing Cash Flow	67	0	0	0	0	0	0	88	-2
Change in Cash	-49	-27	-9	8	-29	-9	-2	39	-37

Korro Bio Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-19	-18	-10	-21	-58	-81	-83	-117
Operating Cash Flow	-17	34	-45	-32	-53	-67	-60	-78
Investing Cash Flow	3	-18	10	-39	11	11	-123	43
Financing Cash Flow	37	142	56	115	0	187	69	0
Change in Cash	24	157	20	44	-42	131	-114	-33

Mutual Funds that own Korro Bio Stock

Check out the Mutual Funds with significant holdings in Korro Bio.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	2.056228%	302793
VANGUARD HORIZON FUNDS	0.599905%	88340
Fidelity Salem Street Trust	0.508765%	74919
Fidelity Concord Street Trust	0.462818%	68153
VANGUARD SCOTTSDALE FUNDS	0.25772%	37951

See all

Global Institutional Holdings in Korro Bio

Funds	Holdings
Vanguard	3.73%
iShares	3.14%
Richard Driehaus	3.06%
F/m	0.44%
Michael Rockefeller	0.34%

See all

Insights on Korro Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, KRRO has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 years, KRRO stock has moved up by 2541.3%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 500.2%

About Korro Bio

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Organisation	Korro Bio
Headquarters	60 First Street, Cambridge, MA, United States, 02141
Industry	Biotechnology
CEO	Dr. Ram Aiyar MBA, Ph.D.
E-voting on shares	Click here to vote

Key Management of Korro Bio

Name	Title
Dr. Ram Aiyar MBA, Ph.D.	CEO, President, Interim CFO, Principal Financial Officer & Director
Dr. Andrew Fraley Ph.D.	Co-Founder & Advisor
Mr. Todd Chappell M.B.A.	Chief Operating Officer
Ms. Stephanie Engels	Chief People Officer
Dr. Gaozhong Zhu Ph.D.	SVP of Chemistry, Manufacturing and Controls & Technical Operations
Dr. Jean-Francois Formela M.D., MBA	Co-Founder & Director
Dr. Loic Vincent Ph.D.	Chief Scientific Officer
Dr. Jeffrey M. Cerio J.D., Pharm.D.	Senior VP, General Counsel & Corporate Secretary
Dr. Joshua Rosenthal Ph.D.	Co-Founder & Advisor
Mr. Oliver Dolan	Senior VP of Finance & Principal Accounting Officer

FAQs

What is Korro Bio share price today?

Korro Bio share price today is $13.18 as on August 22, 2026 at 8:46 am IST at the close of the market. Korro Bio share today touched a day high of $13.48 and a low of $13.02.

What is the 52 week high and 52 week low for Korro Bio share?

Korro Bio share touched a 52 week high of $55.89 on October 16, 2025 and a 52 week low of $5.20 on December 2, 2025. Korro Bio stock price today i.e. August 22, 2026 at 8:46 am IST is closed at $13.18,which is 76.42% down from its 52 week high and 153.25% up from its 52 week low.

What is Korro Bio's market capitalisation today?

Korro Bio market capitalisation is $0.00T as on August 22, 2026 at 8:46 am IST.

How to invest in Korro Bio Stock (KRRO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Korro Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Korro Bio Shares that will get you 0.1138 shares as per Korro Bio share price of $13.18 per share as on August 22, 2026 at 8:46 am IST.

What is the minimum amount required to buy Korro Bio Stock (KRRO) from India?

Indian investors can start investing in Korro Bio (KRRO) shares with as little as ₹95.71 or $1 (as of August 23, 2026 at 9:05 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.10 in Korro Bio stock (as per the Rupee-Dollar exchange rate as on August 23, 2026 at 9:05 pm IST). Based on Korro Bio share’s latest price of $13.18 as on August 22, 2026 at 8:46 am IST, you will get 0.7587 shares of Korro Bio. Learn more about fractional shares .